產地 | 中國 |
品牌 | AntibodySystem |
保存條件 | -20 |
貨號 | DHD30408 |
用途 | 科學研究 |
應用范圍 | 僅用于科研 |
抗原來源 | 重組表達 |
保質期 | 一年 |
抗體名 | bavunalimab |
是否單克隆 | 是 |
克隆性 | 是 |
靶點 | CD223、CD152 |
適應物種 | human |
形態(tài) | 液體 |
宿主 | human |
標記物 | 未標記 |
包裝規(guī)格 | 100ug/支 |
亞型 | half-IGG1-kappa/(scFv-heavy-kappa)-h-CH2-CH3 |
標識物 | 保密 |
濃度 | 1mg/ml% |
免疫原 | 保密 |
是否進口 |
DHD30408
Humanized
Human
Liquid
0.01M PBS, pH 7.4.
1 mg/ml
>95%
Monoclonal
half-IGG1-kappa/(scFv-heavy-kappa)-h-CH2-CH3
Research Grade Pavunalimab Biosimilar
Bispecific,FDC,LAG3,Lymphocyte activation gene 3 protein,CD223,sLAG-3,LAG-3,CD152,Cytotoxic T-lymphocyte protein 4,CTLA-4,CTLA4,Cytotoxic T-lymphocyte-associated antigen 4
Protein A or G purified from cell culture supernatant.
Please contact with the lab for this information.
Mammalian cells
P18627 & P16410
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Bispecific, XmAb-22841, Bavunalimab, CAS: 2329669-78-3
For research use only. Not suitable for clinical or therapeutic use.